共 23 条
[3]
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Yanagisawa M,Kurihara H,Kimura S,et al. Nature . 1988
[4]
Urokinase and tissue plasminogen activators and their inhibitor PAI-1 in human tumors. Gershtein ES,Kushlinskii NE. Bulletin of Experimental Biology and Medicine . 2001
[5]
Impaired fibrinolysis in coronary artery disease. Robert B. Francis,Jr. M.D. David Kawanishi M.D. Terrence Baruch M.D. Peter Mahrer M.D. American Heart Journal . 1988
[6]
Associaton of blood pressure with Fibrinolytic potential in the Framingham offspring population. Poli K A,Tofler G H,larson MG,et al. Circulation . 2000
[7]
Hemostatic factors and the risk ofmyocardial infarction or sudden death in patients with angina pectoris. Thompson SC,Kienast J,Pyke SDM. New England Journal of Medicine, The . 1995
[8]
M arkers of activated coagu lationand the ir usefu lness in the c lin ical laboratory. Tripod i A,M annucc i PM. C linChem . 1996
[9]
Characterization of GMP140 as a circulation plasma protien. Dunlop Cl,Skinner MP,Bendall LJ,et al. Journal of Experimental Medicine, The . 1992
[10]
Intratumoral Lymphatics Are Essential for the Metastatic Spread and Prognosis in Squamous Cell Carcinomas of the Head and Neck Region. Sanna-Mari Maula,Marjana Luukkaa,Reidar Grenman,etal. Cancer Research . 2003